We Think Capricor Therapeutics (NASDAQ:CAPR) Can Afford To Drive Business Growth
Even when a business is losing money, it’s possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment…
